Freund's adjuvant, NOD2 and mycobacteria

Curr Opin Microbiol. 2015 Feb:23:126-32. doi: 10.1016/j.mib.2014.11.015. Epub 2014 Dec 5.

Abstract

Purpose: Mycobacterium tuberculosis contributed to the discovery of delayed-type hypersensitivity and cell-mediated immunity. However, the biochemical basis for the immunogenicity of the mycobacterial cell wall has until recently remained unknown.

Recent findings: Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) responds to bacterial peptidolycan-derived muramyl dipeptide (MDP). Whereas most bacteria produce N-acetyl MDP, mycobacteria produce an unusual modified form of MDP, called N-glycolyl MDP. Disruption of N-glycolyl MDP synthesis in mycobacteria greatly diminishes the contribution of NOD2 to mycobacterial sensing. Additionally, N-glycolyl MDP is more potent and efficacious than N-acetyl MDP at inducing innate responses and T cell-mediated immunity.

Summary: The sensitivity of NOD2 to the mycobacterial peptidoglycan may link the natural history of both innate and adaptive immunity to mycobacterial infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylmuramyl-Alanyl-Isoglutamine / immunology*
  • Acetylmuramyl-Alanyl-Isoglutamine / metabolism*
  • Cell Wall / immunology
  • Cell Wall / metabolism
  • Freund's Adjuvant / metabolism*
  • Immunity, Innate*
  • Mycobacterium tuberculosis / immunology*
  • Nod2 Signaling Adaptor Protein / metabolism*
  • Peptidoglycan / immunology
  • Peptidoglycan / metabolism
  • T-Lymphocytes / immunology*

Substances

  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Peptidoglycan
  • Acetylmuramyl-Alanyl-Isoglutamine
  • Freund's Adjuvant